新坐标发布异动公告，公司股票于2026年1月20日、1月21日、1月22日连续三个交易日内日收盘价格涨 幅偏离值累计超过20%，根据《上海证券交易所交易规则》的有关规定，属于股票交易异常波动的情 形。经公司自查，并向控股股东、实际控制人及其一致行动人书面问询核实，截至本公告发布之日，公 司不存在应披露而未披露的重大信息。公司和控股股东、实际控制人及其一致行动人不存在正在筹划的 可能导致公司股票交易异常波动的其他重大事项。 ...

声明：市场有风险，投资需谨慎。本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库质量等问题，我们无法对数据的真实性及完整性进行分辨或核验， 因此本文内容可能出现不准确、不完整、误导性的内容或信息，具体以公司公告为准。如有疑问，请联 系biz@staff.sina.com.cn。 责任编辑：小浪快报 2026年1月22日，新坐标（sh603040）触及涨停，涨停价115.92元，涨幅9.65%，总市值157.67亿元，流 通市值156.85亿元，截止发稿，总成交额3.72亿元。 根据喜娜AI异动分析，新坐标涨停原因可能如下，业绩增长+现金分红+治理优化： 1、公司基本面良 好，2025年三季度营收同比增长19.45%，归母净利润增长29.41%，扣非净利润增长33.88%，展现出强 劲的业绩增长态势。同时公司实行积极的现金分红政策，每10股派发现金红利2.5元，分红总额3384万 元，占净利润35.58%，这对投资者具有较大吸引力。 2、公司在治理结构上进行了优化，取消监事会改 ...

Core Insights - The article highlights the transformation of Changxiang Biological Technology Co., Ltd. from a frozen meat product company to a player in the ready-to-eat food market, driven by innovation and collaboration with the Central Plains Food Laboratory [1][2] - The Central Plains Food Laboratory has established a comprehensive innovation system that supports traditional food enterprises in enhancing their product offerings and addressing market demands [2][4] Group 1: Company Transformation - Changxiang Biological has successfully developed new products, including spicy chicken snacks, within a year, overcoming challenges related to taste and texture [1] - The company aims to create healthy, additive-free products, leveraging the expertise of the Central Plains Food Laboratory [1][2] Group 2: Innovation and Collaboration - The Central Plains Food Laboratory provides a "one-stop" R&D service, assisting over 280 companies with more than 700 technical services and achieving over 40 key technology breakthroughs [2] - The laboratory operates under a collaborative model involving a central lab, six universities, and multiple technology transfer bases, promoting efficient solutions tailored to individual company needs [2] Group 3: Industry Impact - The food industry in Luohe has grown significantly, with the total scale increasing from 200 billion to 250 billion yuan, accounting for a quarter of the province's food industry and 2.5% of the national total [4] - Luohe is positioning itself as a modern food manufacturing hub, integrating technological, industrial, and financial innovations to enhance its competitive edge in the national market [4]

天和核心舱太空"展翅"，5G基站点亮广袤城乡……这些国之重器的"心脏"里，都有一款核心材料——6微米的 高端压延铜箔。这种薄如蝉翼、轻若无物的铜箔，手指一捻就能撕开，却成为三门峡市材料新城转型蝶变的 金色引擎。 1月20日，记者走进灵宝金源朝辉铜业有限公司（以下简称"朝辉铜业"）智能化生产车间，数台机械臂正精准 抓取卷料，生产线满负荷运转，一派火热景象。6微米的压延铜箔从生产线上"流淌"而出，经激光在线检测 后，被工人麻利地封装、贴标，即将发往全国各地。 围绕这一目标，三门峡创新实施链长制和盟会长制"双长制"，由市委、市政府主要领导任总链长，重点铜企 业任盟会长，系统谋划产业链发展；将铜精深加工产业集群、铜基新材料产业链作为重点培育对象，为产业 "铜板带经过高精度轧机反复碾压产出压延铜箔的过程，就像用擀面杖把面团越擀越薄。"朝辉铜业生产制造 部副部长陈文杰介绍，压延铜箔越薄越软，应用市场就越大，"我们也正是凭借这一核心技术，打破了国际垄 断，成为全球主要压延铜箔研发及生产制造企业之一。今年一季度订单饱满，我们开足马力赶生产、抢进 度，力争实现首季'开门红'，为全年目标任务打下坚实基础。" 三门峡曾因黄金富集而 ...

Core Viewpoint - The article highlights the transformation of the Xuchang power equipment industry cluster towards high-end, intelligent, and green manufacturing, exemplified by the advanced automation in the production of smart electric meters and the development of key technologies in high-voltage direct current (HVDC) systems [1][2]. Group 1: Industry Transformation - The Xuchang power equipment industry cluster has achieved a total output value exceeding 140 billion yuan, positioning itself as a national innovative industrial cluster [1]. - The "black light factory" model has led to a sevenfold increase in per capita production efficiency and a reduction in delivery cycles by nearly half [1]. - The cluster includes major companies like Xuchang Electric and Cape Testing, contributing to a comprehensive integrated industrial ecosystem [1]. Group 2: Technological Advancements - Xuchang has successfully developed China's first HVDC converter valve, breaking the international monopoly on core technologies and reducing costs to one-tenth of foreign counterparts [2]. - The company now holds a 40% market share in global HVDC converter valves and 35% in HVDC control and protection systems, achieving over 20 "China first" and "world first" milestones [2]. - The production of supercharging stations allows electric vehicles to achieve full charge in just 10 minutes, with one in every eight public DC charging stations in China being "Xuchang-made" [2]. Group 3: Innovation and Research - The establishment of the Central Plains Electric Laboratory, supported by provincial government initiatives, focuses on advanced protection control technologies and aims to tackle "bottleneck" technologies [6]. - Xuchang's power equipment industry cluster has built 23 national and provincial innovation platforms and five national postdoctoral workstations, employing 16,000 specialized technical personnel [6]. - The city is committed to becoming a leading hub for intelligent power, prioritizing the power equipment sector in its strategic development [6].

Market Performance - The automotive parts sector increased by 1.26% on January 21, with Weitang Industrial leading the gains [1] - The Shanghai Composite Index closed at 4116.94, up 0.08%, while the Shenzhen Component Index closed at 14255.12, up 0.7% [1] Top Gainers in Automotive Parts Sector - Weitang Industrial (300707) closed at 20.62, up 10.33% with a trading volume of 337,800 shares and a transaction value of 670 million [1] - Weidi Co., Ltd. (603023) closed at 6.11, up 10.09% with a trading volume of 676,500 shares and a transaction value of 409 million [1] - Langbo Technology (603655) closed at 45.28, up 10.01% with a trading volume of 47,600 shares and a transaction value of 209 million [1] - Weichai Heavy Machinery (000880) closed at 33.43, up 10.00% with a trading volume of 118,500 shares and a transaction value of 396 million [1] - New Coordinates (603040) closed at 105.38, up 10.00% with a trading volume of 36,300 shares and a transaction value of 371 million [1] Market Capital Flow - The automotive parts sector saw a net inflow of 173 million from institutional investors, while retail investors contributed a net inflow of 772 million [2] - The sector experienced a net outflow of 945 million from speculative funds [2] Individual Stock Capital Flow - Aotega (002239) had a net inflow of 267 million from institutional investors, while it faced a net outflow of 98.41 million from speculative funds [3] - Mould Technology (000700) saw a net inflow of 241 million from institutional investors, with a net outflow of 114 million from speculative funds [3] - Weichai Heavy Machinery (000880) had a net inflow of 189 million from institutional investors, but faced a significant net outflow of 930 million from speculative funds [3]

Group 1 - The core viewpoint of the news is that New Coordinates (sh603040) reached its daily limit with a price of 105.38 yuan, reflecting a 10% increase and a total market capitalization of 14.38 billion yuan [1] - The company reported a revenue growth of 19.45% year-on-year for Q3 2025, with a net profit increase of 29.41% and a non-recurring net profit growth of 33.88%, indicating strong performance [2] - The company has implemented a cash dividend policy, distributing 2.5 yuan per 10 shares, totaling 33.84 million yuan, which represents 35.58% of its net profit, attracting investor interest [2] Group 2 - The governance structure has been optimized by canceling the supervisory board and establishing an audit committee, along with revising 28 internal regulations, enhancing corporate governance [2] - The automotive parts sector has been active recently due to the growth in new energy vehicle production and sales, benefiting companies like New Coordinates, which supplies precision cold-forged components for automotive engine timing mechanisms [2] - Technical indicators such as the MACD may attract technical investors if a bullish crossover occurs, and there may have been significant capital inflow on the day of the stock's limit-up [2]

"一滴原油"的化学反应为何在此生发？ 信德新材料产业园。 记者 王延辉 摄 在因油而建、因油而兴的濮阳，"一滴原油"的旅程正被重新定义。 1月20日，大寒时节，走进濮阳新型化工基地，将视线从炼油企业河南丰利石化有限公司（以下简称"丰利石 化"）的工业管廊向南延伸，便撞进信德新材料产业园全力拼抢一季度的现场。这里，是"一滴原油"价值"裂 变"的新起点。 寒风中，由银白色管道组成的巨型装置轰鸣不息，蒸汽喷薄，热气腾腾。这是信德新材料产业园一期项目自 去年9月建成后的常态。据统计，该项目试运行两个月即创下12.4亿元产值。 与一期项目一墙之隔，信德新材料产业园二期项目也在去年9月启动建设。塔吊与运输车作业忙碌，为今年6 月投产奠定基础；未来，项目将产出负极前驱体等高附加值新材料，成为产业园"投资超百亿"向"产值超百 亿"跨越的主引擎。 "从油品到化工产品可一站式转化。"信德新材料产业园总经理傅超说，产业园深度嵌入本地产业生态，与丰 利石化、华辰化工形成闭环联动，打通从原油炼制到高端化工新材料的产业链条。 原油是现代石油化工体系的基石。作为我省唯一手握原油进口权和进口原油使用权的地方炼油企业，丰利石 化在濮阳的产业版 ...

Core Viewpoint - The article highlights the rapid development and technological advancements of Duofluoride New Materials Co., Ltd. in the new energy sector, particularly in lithium-ion battery production, and the broader growth of the new materials industry in Jiaozuo City, which is becoming a key pillar of the local economy [1][2][3]. Group 1: Company Developments - Duofluoride's new energy technology company has achieved a daily production capacity of 160,000 battery cells in its fully automated production facility [1]. - The company is a leader in the fluorine materials sector, producing lithium hexafluorophosphate, which is used in one out of every three lithium batteries globally [1]. - Duofluoride's electronic-grade hydrogen fluoride production has reached world-class levels, and its high polymer products have consistently ranked first in global production and sales [2]. Group 2: Industry Growth - Jiaozuo's new materials industry has grown to include 397 enterprises, surpassing a scale of 100 billion yuan, with five major segments: new energy battery materials, modern chemical new materials, aluminum-based and titanium-zirconium alloy materials, green building materials, and superhard materials [3]. - The new materials industry in Jiaozuo has been recognized with several accolades, including the designation of its lithium-ion battery materials cluster as a strategic emerging industry cluster in Henan Province [3]. - Future plans for the new materials industry in Jiaozuo include focusing on solid-state and flow batteries, as well as developing new metal materials and advanced materials like carbon and semiconductor materials [3][4]. Group 3: Collaborative Projects - Jiaozuo has signed agreements with various companies, including a partnership with Hangzhou Jinjiang Group to collaborate on projects related to recycled aluminum and basalt fiber [4]. - Ongoing discussions with Yongjin Technology Group aim to enhance high-end titanium alloy production and industry chain collaboration, positioning Jiaozuo as a significant hub for titanium material processing [4].

Core Viewpoint - The article highlights the transformation of Wang's Group from a traditional construction and real estate company to a player in the biopharmaceutical industry, exemplified by its subsidiary, Zhiwei Pharmaceutical, which has developed innovative drugs and is advancing multiple clinical trials [1][2]. Company Overview - Zhiwei Pharmaceutical has developed a Class I innovative drug, a BTK inhibitor TM471-1, which has entered Phase II clinical trials for one indication, with several others expected to follow [1]. - The company has secured four international PCT patents covering over 30 countries and regions, showcasing its global reach and innovation capabilities [2]. Industry Development - The biopharmaceutical sector is identified as a promising and growing market, with New Xiang City being a strategic hub for this industry, housing over 140 industrial enterprises contributing significantly to the local economy [2]. - The local government has been proactive in fostering the biopharmaceutical industry through partnerships with educational institutions and the establishment of high-level platforms to support innovation [2][4]. Research and Innovation - New Xiang City is home to numerous research and development platforms, including 10 national-level and 140 provincial-level labs, which are crucial for driving advancements in the biopharmaceutical field [4]. - The city is expanding its biopharmaceutical landscape, with nearly 2,000 varieties of products, including blood products, vaccines, and antibiotics, and is leading in several medical fields [4]. Future Prospects - Companies in New Xiang are not only focusing on existing markets but are also venturing into high-end medical devices and diagnostics, indicating a shift towards more advanced healthcare solutions [3]. - The integration of academic research with industry practices is expected to enhance the innovation capacity and market competitiveness of the biopharmaceutical sector in New Xiang [4].